FDA Gets a New Look

Wechsler, Jill
December 2011
Pharmaceutical Representative;Dec2011, Vol. 41 Issue 12, p26
The article focuses on the developments of the Food and Drug Administration (FDA) in the U.S. It states that the agency has been under pressure to encourage medical product development, monitor global supply chain, and accomplish resources. FDA which is being commissioned by Margaret Hamburg has been restructured to handle new scientific approaches global regulatory environment. It also mentions about the agency's continued commitment to address drug safety problems. INSET: Parallel Reviews.


Related Articles

  • FDA Update.  // Pharmaceutical Representative;Dec2011, Vol. 41 Issue 12, p11 

    The article offers updates related to the pharmaceutical industry in the U.S. The Food and Drug Administration (FDA) has approved drugs for diseases including late-stage metastatic melanoma and Hodgkins lymphoma in the U.S. in fiscal year 2011. The drug Eylea which is being marketed by...

  • New FDA Guidelines Encourage Co-Development. Young, Donna // BioWorld Today;12/16/2010, Vol. 21 Issue 242, p2 

    The article focuses on the draft guidance issued by the U.S. Food and Drug Administration (FDA) which encourages drugmakers to develop and test two or more investigational drugs in combination if it would offer a significant advantage to patients. Margaret Hamburg, commissioner of the FDA,...

  • FDA Realigns Drug Inspection and Manufacturing Oversight. Wechsler, Jill // Pharmaceutical Technology Europe;Dec2014, Vol. 26 Issue 12, p20 

    The article offers information on the changes made by the U.S. Food and Drug Administration (FDA) commissioner Margaret Hamburg in operations to improve global market monitoring and the Centre for Drug Evaluation and Research (CDER) reorganisation to support for policies ensuring drug quality....

  • Monograph Makeover Requires Industry Input. Russo, Karen; Dressman, Shawn // Pharmaceutical Technology;May2011, Vol. 35 Issue 5, p90 

    The article focuses on the project of the U.S. Pharmacopeial Convention (USP) which aims to improve the monograph of drug standards. It states that the Food and Drug Administration (FDA) and the Consumer Healthcare Products Association (CHPA) will collaborate with USP for the project. It...

  • FDA Leaders Stress Science and Compliance. Wechsler, Jill // BioPharm International;Oct2009, Vol. 22 Issue 10, p16 

    The article discusses the new rules and policies announced by the newly appointed U.S. Food and Drug Administration (FDA) Commissioner Margaret Hamburg. It states that Hamburg intends to position the FDA as a science-based agency where politics do not override medical judgment and enforce...

  • Tackling Transparency. Wechsler, Jill // Pharmaceutical Executive;Jul2010, Vol. 30 Issue 7, p22 

    The article focuses on the mandates in the healthcare reform legislation in the U.S. concerning the transparency in providing drug information, including formulary listings, out-of-pocket costs and comparative assessments. It notes that a Transparency Initiative is launched by the Food & Drug...

  • Cresting the Slippery Slope. Bennett, Peter A. // Drug Discovery & Development;Jan2012, Vol. 15 Issue 1, p6 

    The author reflects on Teva Pharmaceuticals Industries Ltd.'s application seeking to eliminate age restriction for emergency contraceptive in the U.S. He notes the move of Kathleen Sebelius, Secretary of Health and Human Services (HHS) in sending a memo directing Food and Drug Administration...

  • Senate confirms Hamburg as new commissioner at FDA. McCARTY, MARK // Medical Device Daily;5/20/2009, Vol. 13 Issue 96, p1 

    The article announces the appointment of Margaret Hamburg as commissioner of the U.S. Food & Drug Administration.

  • Hamburg Details Regulatory Science Plan.  // BioWorld Today;10/11/2010, Vol. 21 Issue 196, p4 

    The article reports on a plan by the U.S. Food and Drug Administration (FDA) to spend 25 million U.S. dollars in yet-to-be approved funds to update its regulatory science, as announced by Commissioner Margaret Hamburg in October 2010.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics